For deadly virus sparks debate in China
Claim that concoction ‘can inhibit’ disease triggers frenzied buying as doubts emerge over product’s efficacy
BEIJING: A claim by Chinese scientists that a liquid made with honeysuckle and flowering plants could help fight the deadly coronavirus has sparked frenzied buying of the traditional medicine, but doubts have quickly emerged.
As the death toll from the SARS-like pathogen sweeping the country continues to rise, shoppers have swamped pharmacies in search of “Shuanghuanglian”.
The rush came after state media outlet Xinhua reported on Friday that the Chinese Academy of Sciences had found the concoction “can inhibit” the virus.
Videos shared online showed people in surgical masks lining up at night outside drug stores, purportedly in hope of snapping up the product, despite official advice that people avoid public gatherings to prevent infection.
It quickly sold out both online and at brick-and-mortar stores, but responses to the remedy’s supposed efficacy have ranged from enthusiasm to scepticism on Weibo.
And state media sounded a more cautionary note on Saturday, with broadcaster CCTV publishing an interview with Zhang Boli, one of the researchers leading outbreak containment efforts, who warned of potential side effects from the medicine.
The People’s Daily newspaper said experts advised against taking traditional remedies without professional guidance.
But the claim comes as Beijing looks to incorporate traditional Chinese medicine (TCM) into its nationwide fight against the virus, which has killed more than 300 people and infected over 14,000 in the country.
Yesterday, the Philippines reported the first death outside of China.
Researchers at the state-run academy, a top government think tank, are also studying the potential use of a plant commonly known as Japanese knotweed to alleviate symptoms.
The National Health Commission on Tuesday said TCM practitioners were among nearly 6,000 reinforcement medical personnel being sent to Wuhan in Hubei province, ground zero of the outbreak.
The strategy has reignited a fierce and longrunning debate about the efficacy of TCM, which has a history going back 2,400 years and remains popular in modern-day China.
Marc Freard, a member of the Chinese Medicine Academic Council of France, told AFP he believed traditional formulations could be used to treat people with symptoms ranging from fever to thick phlegm. But he warned that many remedies on the market were of questionable quality and admitted that TCM “lacks scientific standards of efficacy” because it relied on “individualised treatment”.